Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
3 active warrant series covering 24,464,956 shares (~30.2% potential dilution); nearest expiry 2027-10-17.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.14 | Oct 17, 2027 369d | 7.1M | ITM | 8.7% | C$990K | Auto |
| warrant | $0.14 | Nov 28, 2027 411d | 8.3M | ITM | 10.3% | C$1.2M | Auto |
| warrant | $0.14 | Dec 12, 2028 791d | 9.1M | ITM | 11.2% | C$1.3M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 5,690,000 shares (~7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.50 | May 9, 2028 574d | 770K | ITM | 1.0% | C$385K | Auto |
| option | $0.45 | Jun 18, 2030 1344d | 100K | ITM | 0.1% | C$45K | Auto |
| option | $0.09 | Aug 7, 2030 1394d | 2.5M | ITM | 3.0% | C$221K | Auto |
| option | $0.30 | Feb 26, 2031 1597d | 1.0M | ITM | 1.2% | C$300K | Auto |
| option | $0.60 | Oct 29, 2031 1842d | 370K | OTM | 0.5% | C$222K | Auto |
| option | $0.44 | Feb 11, 2035 3043d | 1.0M | ITM | 1.2% | C$440K | Auto |
80,990,749 shares outstanding, plus 24,464,956 from warrants and 5,690,000 from options — a fully diluted 111,145,705 shares, or ~37.2% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.